EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 34 (October 2018) Focus issue F1 Med Sci (Paris), 34 (2018) 81-86 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 34, October 2018
Cancer biomarkers
Page(s) 81 - 86
DOI https://doi.org/10.1051/medsci/201834f114
Publié en ligne 7 novembre 2018
  1. Collins M Wilhelm M Conyers R et al. Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 ; 31 : 2303–2312. [CrossRef] [PubMed] [Google Scholar]
  2. Hasei J Sasaki T Tazawa H et al. Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells. Molecular cancer therapeutics 2013 ; 12 : 314–325. [CrossRef] [PubMed] [Google Scholar]
  3. Mirabello L Troisi RJ Savage SA Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer 2009 ; 115 : 1531–1543. [CrossRef] [PubMed] [Google Scholar]
  4. Zhou W Hao M Du X et al. Advances in targeted therapy for osteosarcoma. Discovery medicine 2014 ; 17 : 301–307. [PubMed] [Google Scholar]
  5. Sakamoto A Iwamoto Y Current status and perspectives regarding the treatment of osteo-sarcoma: chemotherapy. Reviews on recent clinical trials 2008 ; 3 : 228–231. [CrossRef] [PubMed] [Google Scholar]
  6. Glisovic T Bachorik JL Yong J Dreyfuss G RNA-binding proteins and post-transcriptional gene regulation. FEBS letters 2008 ; 582 : 1977–1986. [CrossRef] [PubMed] [Google Scholar]
  7. Nagase T, Seki N, Tanaka A, et al. Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1. DNA research : an international journal for rapid publication of reports on genes and genomes 1995; 2 : 167–74, 99–210. [CrossRef] [PubMed] [Google Scholar]
  8. Bechara Elias G, Sebestyén E, Bernardis I, et al. RBM5, 6, and 10 Differentially Regulate NUMB Alternative Splicing to Control Cancer Cell Proliferation. Molecular Cell 2013; 52 : 720–33. [Google Scholar]
  9. Wang Y Gogol-Doring A Hu H et al. Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulation. EMBO molecular medicine 2013 ; 5 : 1431–1442. [CrossRef] [PubMed] [Google Scholar]
  10. Zheng S Damoiseaux R Chen L Black DL A broadly applicable high-throughput screening strategy identifies new regulators of Dlg4 (Psd-95) alternative splicing. Genome research 2013 ; 23 : 998–1007. [CrossRef] [PubMed] [Google Scholar]
  11. Inoue A Yamamoto N Kimura M et al. RBM10 regulates alternative splicing. FEBS letters 2014 ; 588 : 942–947. [CrossRef] [PubMed] [Google Scholar]
  12. Hernandez J Bechara E Schlesinger D et al. Tumor suppressor properties of the splicing regulatory factor RBM10. RNA biology 2016 ; 13 : 466–472. [CrossRef] [PubMed] [Google Scholar]
  13. Atsumi T Suzuki H Jiang JJ et al. Rbm10 regulates inflammation development via alternative splicing of Dnmt3b. International immunology 2017 ; 29 : 581–591. [CrossRef] [PubMed] [Google Scholar]
  14. Sutherland LC Thibault P Durand M et al. Splicing arrays reveal novel RBM10 targets, including SMN2 pre-mRNA. BMC molecular biology 2017 ; 18 : 19. [CrossRef] [PubMed] [Google Scholar]
  15. Vinayanuwattikun C Le Calvez-Kelm F Abedi-Ardekani B et al. Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma. Scientific reports 2016 ; 6 : 31628. [CrossRef] [PubMed] [Google Scholar]
  16. Imielinski M Berger AH Hammerman PS et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 2012 ; 150 : 1107–1120. [CrossRef] [PubMed] [Google Scholar]
  17. Sebestyen E Singh B Minana B et al. Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks. Genome research 2016 ; 26 : 732–744. [CrossRef] [PubMed] [Google Scholar]
  18. Giannakis M Mu XJ Shukla SA et al. Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma. Cell reports 2016 ; 15 : 857–865. [CrossRef] [PubMed] [Google Scholar]
  19. Furukawa T Kuboki Y Tanji E et al. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Scientific reports 2011 ; 1 : 161. [CrossRef] [PubMed] [Google Scholar]
  20. Witkiewicz AK McMillan EA Balaji U et al. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nature communications 2015 ; 6 : 6744. [CrossRef] [PubMed] [Google Scholar]
  21. Ibrahimpasic T Xu B Landa I et al. Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 ; 23 : 5970–5980. [CrossRef] [PubMed] [Google Scholar]
  22. Lukong KE Chang KW Khandjian EW Richard S RNA-binding proteins in human genetic disease. Trends in genetics : TIG 2008 ; 24 : 416–425. [CrossRef] [PubMed] [Google Scholar]
  23. Guan G Li R Tang W et al. Expression of RNA-binding motif 10 is associated with advanced tumor stage and malignant behaviors of lung adenocarcinoma cancer cells. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 ; 39 : 1010428317691740. [PubMed] [Google Scholar]
  24. Wang K Bacon ML Tessier JJ et al. RBM10 Modulates Apoptosis and Influences TNF-alpha Gene Expression. Journal of cell death 2012 ; 5 : 1–19. [PubMed] [Google Scholar]
  25. Zhao J Sun Y Huang Y et al. Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing. Scientific reports 2017 ; 7 : 40488. [CrossRef] [PubMed] [Google Scholar]
  26. Loiselle JJ Roy JG Sutherland LC RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5. PloS one 2017 ; 12 : e0180258. [CrossRef] [PubMed] [Google Scholar]
  27. Steeg PS Tumor metastasis: mechanistic insights and clinical challenges. Nature medicine 2006 ; 12 : 895–904. [CrossRef] [PubMed] [Google Scholar]
  28. Chambers AF Groom AC MacDonald IC Dissemination and growth of cancer cells in metastatic sites. Nature reviews Cancer 2002 ; 2 : 563–572. [CrossRef] [PubMed] [Google Scholar]
  29. Rotem A Janzer A Izar B et al. Alternative to the soft-agar assay that permits high-throughput drug and genetic screens for cellular transformation. Proceedings of the National Academy of Sciences of the United States of America 2015 ; 112 : 5708–5713. [CrossRef] [PubMed] [Google Scholar]
  30. Ji Y Xie S Jiang L et al. Increased cell apoptosis in human lung adenocarcinoma and in vivo tumor growth inhibition by RBM10, a tumor suppressor gene. Oncology letters 2017 ; 14 : 4663–4669. [CrossRef] [PubMed] [Google Scholar]
  31. Bechara EG Sebestyen E Bernardis I et al. RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation. Mol Cell 2013 ; 52 : 720–733. [CrossRef] [PubMed] [Google Scholar]
  32. James CG Ulici V Tuckermann J et al. Expression profiling of Dexamethasone-treated primary chondrocytes identifies targets of glucocorticoid signalling in endochondral bone development. BMC genomics 2007 ; 8 : 205. [CrossRef] [PubMed] [Google Scholar]
  33. Kiraz Y Adan A Kartal Yandim M, Baran Y. Major apoptotic mechanisms and genes involved in apoptosis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2016 ; 37 : 8471–8486. [CrossRef] [PubMed] [Google Scholar]
  34. Martinez-Arribas F Agudo D Pollan M et al. Positive correlation between the expression of X-chromosome RBM genes (RBMX, RBM3, RBM10) and the proapoptotic Bax gene in human breast cancer. Journal of cellular biochemistry 2006 ; 97 : 1275–1282. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.